Immunologix boosts Translational Sciences division with new recruits
Immunologix bolsters its scientific expertise with two new hires to build on its bioanalytical biomarker programs created from the launch of its Translational Sciences division.
Immunologix bolsters its scientific expertise with two new hires to build on its bioanalytical biomarker programs created from the launch of its Translational Sciences division.
Icon launches web-based patient engagement platform to provide patients with study-specific information and connectivity.
Adimab expands partnerships with Takeda and Regeneron to enable biopharmaceutical companies with discovery and optimization capabilities.
Mispro is expanding its vivarium service network with the opening of its fifth facility, an 18,000 square foot facility in Broad Hollow Bioscience Park, NY.
Recipharm is launching inhalation product solutions following its acquisition of Sanofi’s inhalation manufacturing business and increased use of inhaled drug products.
Teva is at the centre of the allegations made by 44 US states, which suggests a number of companies collaborated to raise prices by as much as 2,000%.
Par Pharmaceutical initiates a recall of mycophenolate mofetil injection, after a vial containing a glass fragment was discovered during reconstitution.
Troubleshooting in Mylan’s Morgantown facility, after a US FDA warning, has hurt the company’s first quarter results.